{"id":"W2944809072","doi":"10.1016/j.jcjd.2019.04.012","title":"Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sanofi (Canada); LMC Diabetes & Endocrinology (Canada)","funders":"Gilead Sciences; Amgen; Pfizer; Janssen Pharmaceuticals; Juvenile Diabetes Research Foundation Canada; Juvenile Diabetes Research Foundation United States of America; AstraZeneca; Eli Lilly and Company; Novo Nordisk; Sanofi; Merck","keywords":"Medicine; Insulin glargine; Type 2 diabetes; Diabetes mellitus; Insulin; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00307504,0.0003871944,0.001170609,0.001419387,0.0001992027,0.0001289056,0.0006621162,0.0001208362,0.000113209],"category_scores_gemma":[0.0007870054,0.0002272582,0.00009364713,0.002403742,0.0003483805,0.0002097049,0.00006295922,0.001012337,0.000009422672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005962874,"about_ca_system_score_gemma":0.00330151,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1320588,"about_ca_topic_score_gemma":0.8940357,"domain_scores_codex":[0.9959025,0.0005909301,0.001055349,0.0004005714,0.0007815129,0.001269186],"domain_scores_gemma":[0.9966494,0.0004742414,0.0005680277,0.0007940217,0.0005868015,0.00092745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000910248,0.0002353721,0.9899866,0.0003377313,0.0002626348,0.00004615349,0.002111337,0.0000438064,0.000009504011,0.000107102,0.001991969,0.004776778],"study_design_scores_gemma":[0.003468672,0.003877552,0.9849007,0.0009681726,0.00008546683,5.737463e-7,0.002022122,0.0002286652,0.00002736179,0.000104279,0.004078089,0.0002383341],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9765262,0.002770108,2.259242e-8,0.01735451,0.0002655365,0.00178682,0.00006325573,0.000007776048,0.001225787],"genre_scores_gemma":[0.9976545,0.0001088635,0.00003844431,0.001707292,0.00009859061,0.00002227824,0.00005525129,0.00005102039,0.0002637358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7619769,"threshold_uncertainty_score":0.9267319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01844105004292507,"score_gpt":0.2774945769895215,"score_spread":0.2590535269465964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}